Monash University researchers, alongside key partner Halozyme Therapeutics, report findings in support of shifting the way ...
The combination of subcutaneous daratumumab with VRd was approved in July 2024 for induction and consolidation in patients ...
AIM: The “2026 Guideline for the Early Management of Patients With AIS” replaces the “2018 Guidelines for the Early Management of Patients With AIS” and the 2019 update to reflect recent advances in ...
The Central Drugs Standard Control Organisation (CDSCO) has granted multiple CT-18 approvals between January 2020 and ...
Everyday Health on MSN
How to plan for successful home SCIg self-administration for primary immunodeficiency
Learn how to self-administer SCIg at home for primary immunodeficiency. Tips on preparation, reducing pain, managing ...
Considering a switch from IVIg to SCIg for primary immunodeficiency? Explore differences in responsibility, side effects, ...
US company PreEvnt has unveiled a non-invasive blood sugar monitoring device at CES 2026 in Las Vegas. This was reported by US magazine Wired. According to the manufacturer, the device is suitable for ...
SEATTLE — Rehearsing to ring in the new year is a big job, and the technical team has been hard at work, preparing and practicing to make sure the night goes smoothly. "It's something that I've been ...
SUZHOU, China, Dec. 29, 2025 /PRNewswire/ — Alphamab Oncology (Stock Code: 9966.HK) announced that the IND application for a Phase II clinical study of JSKN033 (a proprietary high-concentration ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results